WoodTrust Financial Corp lifted its stake in Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 262.9% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 57,700 shares of the company’s stock after acquiring an additional 41,800 shares during the period. WoodTrust Financial Corp’s holdings in Waystar were worth $1,462,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently bought and sold shares of the company. Canada Pension Plan Investment Board acquired a new position in Waystar during the 2nd quarter valued at approximately $390,593,000. BlackRock Inc. acquired a new stake in shares of Waystar during the second quarter worth $357,950,000. Advent International L.P. purchased a new stake in shares of Waystar during the second quarter valued at $227,060,000. Jupiter Topco LLC purchased a new stake in shares of Waystar during the second quarter valued at $58,960,000. Finally, Bank of America Corp DE acquired a new position in shares of Waystar in the 2nd quarter valued at $53,031,000.
Waystar Stock Performance
NASDAQ:WAY traded down $0.44 during mid-day trading on Friday, hitting $26.04. The company’s stock had a trading volume of 420,852 shares, compared to its average volume of 2,574,489. The business’s fifty day moving average is $24.93 and its two-hundred day moving average is $22.80. The stock has a market cap of $4.99 billion, a price-to-earnings ratio of 37.19, a PEG ratio of 1.00 and a beta of 0.18. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.85 and a quick ratio of 1.85. Waystar Holding Corp. has a 1 year low of $17.26 and a 1 year high of $40.35.
Analyst Upgrades and Downgrades
WAY has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $39.00 target price on shares of Waystar in a research note on Friday, July 31st. Morgan Stanley restated an “equal weight” rating and issued a $28.00 price objective on shares of Waystar in a research note on Wednesday, September 16th. Barclays downgraded Waystar from an “overweight” rating to an “equal weight” rating and lifted their target price for the stock from $27.00 to $30.00 in a report on Tuesday, September 15th. Citigroup reiterated a “buy” rating on shares of Waystar in a report on Monday, July 20th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of Waystar in a research report on Tuesday, September 15th. Two research analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Waystar presently has a consensus rating of “Moderate Buy” and an average price target of $34.67.
View Our Latest Stock Analysis on Waystar
Insiders Place Their Bets
In other Waystar news, CEO Matthew Hawkins sold 82,500 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $26.23, for a total value of $2,163,975.00. Following the completion of the transaction, the chief executive officer directly owned 1,804,794 shares of the company’s stock, valued at approximately $47,339,746.62. The trade was a 4.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 247,500 shares of company stock worth $6,370,499 in the last three months. 3.50% of the stock is currently owned by company insiders.
Waystar Company Profile
Waystar Holding Corp. is a healthcare technology company that provides cloud-based software for managing healthcare payments and revenue cycle operations. Its platform connects healthcare providers, payers and patients to help streamline administrative and financial workflows across the healthcare system.
The company’s products and services include eligibility and benefits verification, claims management and submission, prior authorization, payment processing, patient billing, denial management and revenue cycle analytics.
See Also
- Five stocks we like better than Waystar
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding WAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waystar Holding Corp. (NASDAQ:WAY – Free Report).
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
